# Elite Pharmaceuticals Inc: Form 8-K, filed Oct 7, 2024

- Company: [Elite Pharmaceuticals Inc](/companies/eltp.md) (CIK 1053369)
- Form: 8-K
- Filed: 2024-10-07
- Accepted by EDGAR: Oct 7, 2024, 16:20 ET
- Period: 2024-10-07
- Accession: 0001493152-24-040288
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1053369/000149315224040288/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1053369/000149315224040288/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1053369/000149315224040288/form8-k.htm

Filed Oct 7, 2024.
Source: SEC EDGAR, the filing index for accession 0001493152-24-040288. Last ingested by Listed: Nov 3, 2026, 08:34 ET. No prices; not investment advice.